FIELD: medicine.
SUBSTANCE: invention relates to medicine and aims at correction of isoniazid-induced hepatotoxic reactions. Method comprises using amaranth seed oil, produced by cold pressing of germs and shells of amaranth seeds, in a dose of 200 mg (2 gelatine capsules) 3 times a day, 1 hour before meals until clinical-laboratory values is normalized and another 1-2 weeks. At extension of the anti-tuberculosis therapy the said is used as continuous assistance with the interval between courses of 1 month.
EFFECT: method allows reducing intoxication symptoms and normalizing metabolic and morphological hepatic disorders at isoniazid-induced acute disorders.
1 cl, 3 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF COMPLICATIONS INDUCED BY ISONIAZID | 2015 |
|
RU2597788C1 |
| THERAPEUTIC AGENT FOR PREVENTING AND TREATING CHRONIC LIVER DISEASES | 2012 |
|
RU2526172C2 |
| MEANS FOR BODY MICROCIRCULATORY PROCESSES IMPROVEMENT AND METHOD FOR ITS APPLICATION | 2015 |
|
RU2646463C2 |
| METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
| METHOD FOR REDUCING TOXIC DAMAGE OF RATS' LIVER BY A CARBON TETRACHLORATED | 2018 |
|
RU2678313C1 |
| METHOD FOR REDUCING NEUROTOXICITY CAUSED BY A COMPLEX OF ANTI-TUBERCULOSIS DRUGS IN EXPERIMENT | 2023 |
|
RU2820957C1 |
| MEDICINAL FORMULATION ELICITING ANTITUBERCULOSIS EFFECT | 2002 |
|
RU2241445C2 |
| EXPERIMENTAL TOXIC CHRONIC HEPATITIS TREATMENT METHOD | 2009 |
|
RU2392000C1 |
| METHOD FOR TREATING EXPERIMENTAL CHRONIC TOXIC HEPATITIS | 2005 |
|
RU2295971C1 |
| HEPATOPROTECTIVE AGENT FROM ALGAE | 2013 |
|
RU2528898C1 |
